A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Erin McGovern et al.|Clinical Cancer Research|2023Cited by 34
Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2023Cited by 0
Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2023Cited by 0
Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with MyelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2023Cited by 0
Supplementary Figure S5 from A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosisJohn Mascarenhas, Ronald Hoffman, Anna Ritá Migliaccio et al.|Unknown|2024Cited by 0